When myelofibrosis occurs, some people may not have any symptoms, while others have severe symptoms that require immediate treatment. This article will explain the symptoms of myelofibrosis ...

"So built into every myelofibrosis or MPN patient visit ... Other clues that the disease is progressing include patient symptoms, including B symptoms -- drenching night sweats, fatigue that ...

Panelists discuss how myelofibrosis progresses from its molecular and genetic origins through various clinical manifestations ...

Around 100,000 Australians live with a rare form of blood cancer, and a new treatment approved by the medicines watchdog is ...

Around 100,000 Australians live with myelofibrosis, which is a rare form of blood cancer. But an Australian-developed drug - ...

Current therapies for myelofibrosis, like Novartis/Incyte's JAK1/2 inhibitor Jakafi (ruxolitinib), can help relieve symptoms of myelofibrosis and improve long-term survival, but can exacerbate ...

The health technology assessment (HTA) agency has recommended Inrebic (fedratinib) for treating disease-related splenomegaly (enlarged spleen) or other symptoms in myelofibrosis in patients ...

Myelofibrosis is a type of blood cancer that causes fibrosis in the bone marrow, anemia and enlarged spleen, amongst other symptoms. The study is testing three dose levels of OPN-2853 (20 mg ...